Medi-Tech Insights Research Reports

Medi-Tech Insight's Key Research Findings in the Digital Pathology market research report. Pathology is an area where digitization and automation can bring about significant benefits to patients, physicians, pathologists & labs/hospitals. Consider the following startling facts: 97% of departments don’t have enough histopathologists for the workload, and that workload is rising 19 hours/day are spent on physical slide logistics (reported in laboratory with 220 cases/day) An estimated 98% of pathologists are relying on manual workflows and microscopes for primary diagnosis, which can cause delays and inefficiencies, and create barriers for remote collaboration Digital Pathology has been around for many years, but the current Covid-19 pandemic has underlined the benefits it can offer to labs, hospitals, clinicians and pathologists. The benefits are multi-fold: Improves efficiency workflow Faster turnaround time leading to benefits for labs, patients & clinicians Pathologists

The global digital therapeutics market is valued at  $ 2.2 billion (2020) and is set to gain significant momentum. The next phase of growth is likely to be driven by growing pharma-digital therapeutic alliances, growing focus of digital therapeutics companies on mental health, psychiatric conditions and cognitive impairments, gradually improving reimbursement scenario, favorable funding environment and strong pipeline of digital therapeutics products. Changing medical protocols, need to curtail costs, evolution and widespread adoption of technology specifically in the areas of artificial intelligence, deep learning and health monitoring using wearables is increasingly transforming healthcare and has paved the way for a new class of therapeutics known as digital therapeutics (DTx). Digital therapeutics are products (software programs) that deliver evidence-based therapeutic interventions to patients to prevent, manage, or treat a medical disorder or disease (Source: Digital Therapeutic

Medi-Tech Insights  latest  research analysis reveals a huge , untapped  growth opportunity of over $10  B illion in the U.S Remote Patient Monitoring (RPM) market.    Healthcare is a field that is rapidly developing  and is marked by incessant advancements  in technology and services . A significant  development in this  field  is remote monitoring of patients which  offers several  advantages in a  fast-aging  world population with  growing  health complications.  The technology has developed to the extent  that  patient s  can be  monitored not only inside   hospitals rooms but also  at home with the use of modern communication and sensor technologies.  Technological advancements in  remote patient monitoring  devices allows  monitoring  of   multiple  vital sign  parameters  such as   blood pressure ,  heart rate, respiration rate, electrocardiogram reading ,  temperature, blood glucose levels , among others .  The technology is being used to monitor a diverse group of individuals